{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:32:36Z","timestamp":1791689556999,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.4158\/ep151184.or","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T17:44:42Z","timestamp":1470159882000},"page":"1267-1276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Clinical Characteristics and Efficacy of Bisphosphonates in Audlt Patients with Osteogenesis Impergecta"],"prefix":"10.1016","volume":"22","author":[{"given":"Xiao-jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dou-dou","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-bo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ping","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP151184.OR_bb0010","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/bonekey.2015.143","article-title":"Value of rare low bone mass diseases for osteoporosis genetics","volume":"5","author":"Costantini","year":"2016","journal-title":"Bonekey Rep"},{"key":"10.4158\/EP151184.OR_bb0015","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"key":"10.4158\/EP151184.OR_bb0020","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164A","author":"Van Dijk","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.4158\/EP151184.OR_bb0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/bmj.312.7027.351","article-title":"Life expectancy in osteogenesis imperfecta","volume":"312","author":"Paterson","year":"1996","journal-title":"BMJ"},{"key":"10.4158\/EP151184.OR_bb0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13023-015-0362-2","article-title":"Initial report of the osteogenesis imperfecta adult natural history initiative","volume":"10","author":"Tosi","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.4158\/EP151184.OR_bb0035","first-page":"CD005088","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"7","author":"Dwan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP151184.OR_bb0040","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/jbmr.2567","article-title":"Intravenous bisphosphonate therapy of young children with osteogenesis imperfecta: skeletal findings during follow up throughout the growing years","volume":"30","author":"Palomo","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP151184.OR_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000381713","article-title":"Efficacy and safety of bisphosphonate therapy in children with osteogenesis imperfecta: a systematic review","volume":"84","author":"Rijks","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.4158\/EP151184.OR_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1875-9572(09)60002-4","article-title":"Intravenous pamidronate therapy in Taiwanese patients with osteogenesis imperfecta","volume":"49","author":"Lin","year":"2008","journal-title":"Pediatr Neonatol"},{"key":"10.4158\/EP151184.OR_bb0055","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/EJE-14-0017","article-title":"Treatment of osteogenesis imperfecta in adults","volume":"171","author":"Lindahl","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP151184.OR_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00223-015-0021-6","article-title":"Bisphosphonate treatment of children and adults with osteogenesis imperfecta: unanswered questions","volume":"97","author":"Brizola","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.4158\/EP151184.OR_bb0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.clnu.2015.05.019","article-title":"High prevalence of vitamin D deficiency in urban health checkup population","volume":"35","author":"Ning","year":"2016","journal-title":"Clin Nutr"},{"key":"10.4158\/EP151184.OR_bb0070","doi-asserted-by":"crossref","first-page":"e103841","DOI":"10.1371\/journal.pone.0103841","article-title":"Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.4158\/EP151184.OR_bb0075","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1172\/JCI74230","article-title":"Osteogenesis imperfecta in adults","volume":"124","author":"Bishop","year":"2014","journal-title":"J Clin Invest"},{"key":"10.4158\/EP151184.OR_bb0080","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJM198406283102602","article-title":"Osteogenesis imperfecta after the menopause","volume":"310","author":"Paterson","year":"1984","journal-title":"N Engl J Med"},{"key":"10.4158\/EP151184.OR_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bone.2008.11.006","article-title":"Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations","volume":"44","author":"Garnero","year":"2009","journal-title":"Bone"},{"key":"10.4158\/EP151184.OR_bb0090","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1373\/clinchem.2006.083055","article-title":"Bone formation markers in adults with mild osteogenesis imperfecta","volume":"53","author":"Cundy","year":"2007","journal-title":"Clin Chem"},{"key":"10.4158\/EP151184.OR_bb0095","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","article-title":"Bone turnover markers in patients with osteogenesis imperfecta","volume":"34","author":"Braga","year":"2004","journal-title":"Bone"},{"key":"10.4158\/EP151184.OR_bb0100","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00198-015-3156-4","article-title":"Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta","volume":"26","author":"Kocijan","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP151184.OR_bb0105","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jbmr.1592","article-title":"Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT","volume":"27","author":"Folkestad","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP151184.OR_bb0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP151184.OR_bb0115","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","article-title":"Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial","volume":"21","author":"Chevrel","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP151184.OR_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00198-011-1658-2","article-title":"Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists","volume":"23","author":"Bradbury","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP151184.OR_bb0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1359\/jbmr.2003.18.1.126","article-title":"Intravenous neridronate in adults with osteogenesis imperfecta","volume":"18","author":"Adami","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP151184.OR_bb0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1359\/JBMR.050312","article-title":"Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP151184.OR_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00223-010-9383-y","article-title":"Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta","volume":"87","author":"Shapiro","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.4158\/EP151184.OR_bb0140","first-page":"225","article-title":"Osteogenesis imperfecta in adults: phenotypic characteristics and response to treatment in an Irish cohort","volume":"183","author":"O'Sullivan","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.4158\/EP151184.OR_bb0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.endonu.2010.03.017","article-title":"Effects of zoledronic acid in adults with osteogenesis imperfecta [in Spanish]","volume":"57","author":"Pav\u00f3n de Paz","year":"2010","journal-title":"Endocrinol Nutr"},{"key":"10.4158\/EP151184.OR_bb0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1359\/JBMR.051006","article-title":"Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta","volume":"21","author":"DiMeglio","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP151184.OR_bb0155","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00198-011-1583-4","article-title":"Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass","volume":"23","author":"Hadji","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP151184.OR_bb0160","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1210\/jc.2012-2804","article-title":"Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation","volume":"97","author":"Shane","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP151184.OR_bb0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2012-4195","article-title":"The paradox of prevention--bilateral atypical subtrochanteric fractures due to bisphosphonates in osteogenesis imperfecta","volume":"98","author":"Manolopoulos","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP151184.OR_bb0170","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3109\/17453674.2012.729183","article-title":"Atypical femoral fracture following bisphosphonate treatment in a woman with osteogenesis imperfecta--a case report","volume":"83","author":"Meier","year":"2012","journal-title":"Acta Orthop"},{"key":"10.4158\/EP151184.OR_bb0175","first-page":"278","article-title":"An atypical fracture in male patient with osteogenesis imperfecta","volume":"12","author":"Etxebarria-Foronda","year":"2015","journal-title":"Clin Cases Miner Bone Metab"},{"key":"10.4158\/EP151184.OR_bb0180","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.4158\/EP14141.CR","article-title":"Atypical femoral fracture in an osteogenesis imperfecta patient successfully treated with teriparatide","volume":"20","author":"Holm","year":"2014","journal-title":"Endocr Pract"},{"key":"10.4158\/EP151184.OR_bb0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00774-011-0331-3","article-title":"Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw","volume":"30","author":"Maines","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"10.4158\/EP151184.OR_bb0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tjog.2012.04.029","article-title":"Uncomplicated vaginal delivery in two consecutive pregnancies carried to term in a woman with osteogenesis imperfecta type I and bisphosphonate treatment before conception","volume":"51","author":"Chen","year":"2012","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.4158\/EP151184.OR_bb0195","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1210\/jc.2005-2548","article-title":"Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases","volume":"91","author":"Chan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP151184.OR_bb0200","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bone.2016.02.013","article-title":"Effect of high-dose vitamin D supplementation on bone density in youth with osteogenesis imperfecta: a randomized controlled trial","volume":"86","author":"Plante","year":"2016","journal-title":"Bone"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035583X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035583X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:34Z","timestamp":1761515974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2035583X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1530891X2035583X"],"URL":"https:\/\/doi.org\/10.4158\/ep151184.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Characteristics and Efficacy of Bisphosphonates in Audlt Patients with Osteogenesis Impergecta","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP151184.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}